<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39337889</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>Relationship of Non-Invasive Arterial Stiffness Parameters with 10-Year Atherosclerotic Cardiovascular Disease Risk Score in Post-COVID-19 Patients-The Results of a Cross-Sectional Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1105</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life14091105</ELocationID><Abstract><AbstractText>This study evaluated the relationship of non-invasive arterial stiffness parameters with an individual 10-year risk of fatal and non-fatal atherosclerotic cardiovascular disease (ASCVD) events in the cohort post-coronavirus disease 2019 (COVID-19). The study group included 203 convalescents aged 60.0 (55.0-63.0) and 115 (56.7%) women. The ASCVD risk was assessed as low to moderate to very high based on medical history (for 62 participants with pre-existing ASCVD/diabetes/chronic kidney disease in the entire cohort) or calculated in percentages using the Systemic Coronary Risk Evaluation 2 (SCORE2) algorithm based on age, sex, smoking status, systolic blood pressure (BP), and non-high-density lipoprotein cholesterol (for 141 healthy participants). The stiffness index (SI) and reflection index (RI) measured by photoplethysmography, as well as pulse pressure (PP), calculated as the difference between systolic and diastolic BP, were markers of arterial stiffness. Stiffness parameters increased significantly with the increase in ASCVD risk in the entire cohort. In 30 (14.8%) patients in the low- to moderate-risk group, the median SI was 8.07 m/s (7.10-8.73), RI 51.40% (39.40-65.60), and PP 45.50 mmHg (40.00-57.00); in 111 (54.7%) patients in the high-risk group, the median SI was 8.70 m/s (7.40-10.03), RI 57.20% (43.65-68.40), and PP 54.00 mmHg (46.00-60.75); and in 62 (30.5%) patients in the very-high-risk group, the median was SI 9.27 m/s (7.57-10.44), RI 59.00% (50.40-72.40), and PP 60.00 mmHg (51.00-67.00). In healthy participants, the SI ≤ 9.0 m/s (sensitivity of 92.31%, area under the curve [AUC] 0.686, <i>p</i> &lt; 0.001) based on the receiver operating characteristics was the most sensitive variable for discriminating low to moderate risk, and PP &gt; 56.0 mmHg (sensitivity of 74.36%, AUC 0.736, <i>p</i> &lt; 0.001) was used for discriminating very high risk. In multivariate logistic regression, younger age, female sex, PP ≤ 50 mmHg, SI ≤ 9.0 m/s, and triglycerides &lt; 150 mg/dL had the best relationship with low to moderate SCORE2 risk. In turn, older age, currently smoking, PP &gt; 56.0 mmHg, RI &gt; 68.6%, and diastolic BP ≥ 90 mmHg were related to very high SCORE2 risk. In conclusion, arterial stiffness is significantly related to ASCVD risk in post-COVID-19 patients and can be helpful as a single risk marker in everyday practice. Cut-off points for arterial stiffness parameters determined based on SCORE2 may help make individual decisions about implementing lifestyle changes or pharmacological treatment of ASCVD risk factors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Loboda</LastName><ForeName>Danuta</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2932-6269</Identifier><AffiliationInfo><Affiliation>Department of Electrocardiology and Heart Failure, Medical University of Silesia in Katowice, 40-635 Katowice, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarecka-Hujar</LastName><ForeName>Beata</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-0002-8591</Identifier><AffiliationInfo><Affiliation>Department of Basic Biomedical Science, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nowacka-Chmielewska</LastName><ForeName>Marta</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8668-8878</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Biology, Institute of Physiotherapy and Health Sciences, Academy of Physical Education in Katowice, 40-065 Katowice, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szoltysek-Boldys</LastName><ForeName>Izabela</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of General and Inorganic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zielinska-Danch</LastName><ForeName>Wioleta</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-1241-6225</Identifier><AffiliationInfo><Affiliation>Department of General and Inorganic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibinski</LastName><ForeName>Michal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Electrocardiology and Heart Failure, Medical University of Silesia in Katowice, 40-635 Katowice, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilczek</LastName><ForeName>Jacek</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Electrocardiology and Heart Failure, Medical University of Silesia in Katowice, 40-635 Katowice, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gardas</LastName><ForeName>Rafal</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Electrocardiology and Heart Failure, Medical University of Silesia in Katowice, 40-635 Katowice, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grabowski</LastName><ForeName>Mateusz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Biology, Institute of Physiotherapy and Health Sciences, Academy of Physical Education in Katowice, 40-065 Katowice, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lejawa</LastName><ForeName>Mateusz</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1228-7534</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Biology, Institute of Physiotherapy and Health Sciences, Academy of Physical Education in Katowice, 40-065 Katowice, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 41-808 Zabrze, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malecki</LastName><ForeName>Andrzej</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Biology, Institute of Physiotherapy and Health Sciences, Academy of Physical Education in Katowice, 40-065 Katowice, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golba</LastName><ForeName>Krzysztof S</ForeName><Initials>KS</Initials><Identifier Source="ORCID">0000-0001-5722-7976</Identifier><AffiliationInfo><Affiliation>Department of Electrocardiology and Heart Failure, Medical University of Silesia in Katowice, 40-635 Katowice, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>019/RID/2018/19</GrantID><Agency>Center for Research and Implementation of Strategy Supporting Healthy Aging (RIDage)" financed by the Polish Ministry of Education and Science in the Regional Excellence Initiative program</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 disease</Keyword><Keyword MajorTopicYN="N">Systematic Coronary Risk Evaluation 2 algorithm</Keyword><Keyword MajorTopicYN="N">arterial stiffness</Keyword><Keyword MajorTopicYN="N">atherosclerotic cardiovascular diseases</Keyword><Keyword MajorTopicYN="N">risk prediction</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39337889</ArticleId><ArticleId IdType="pmc">PMC11433112</ArticleId><ArticleId IdType="doi">10.3390/life14091105</ArticleId><ArticleId IdType="pii">life14091105</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO’s World Health Report  The Top 10 Causes of Death.  [(accessed on 30 June 2024)].  Available online:  https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.</Citation></Reference><Reference><Citation>Tian Y., Li D., Cui H., Zhang X., Fan X., Lu F. Epidemiology of multimorbidity associated with atherosclerotic cardiovascular disease in the United States, 1999–2018. BMC Public Health. 2024;24:267. doi: 10.1186/s12889-023-17619-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-17619-y</ArticleId><ArticleId IdType="pmc">PMC10804461</ArticleId><ArticleId IdType="pubmed">38262992</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Disease Burden and Mortality Estimates.  [(accessed on 30 June 2024)].  Available online:  www.who.int/healthinfo/global_burden_disease/estimates/en.</Citation></Reference><Reference><Citation>Łoboda D., Sarecka-Hujar B., Wilczek J., Gibiński M., Zielińska-Danch W., Szołtysek-Bołdys I., Paradowska-Nowakowska E., Nowacka-Chmielewska M., Grabowski M., Lejawa M., et al. Cardiac status and atherosclerotic cardiovascular risk of convalescents after COVID-19 in Poland. Pol. Arch. Intern. Med. 2023;133:16449. doi: 10.20452/pamw.16449.</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.16449</ArticleId><ArticleId IdType="pubmed">36861463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanecki K., Nitsch-Osuch A., Goryński P., Wojtyniak B., Juszczyk G., Magdalena B., Kosińska I., Tyszko P. Hospitalizations for COVID-19 in Poland: A study based on data from a national hospital register. Pol. Arch. Intern. Med. 2021;131:535–540. doi: 10.20452/pamw.15946.</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.15946</ArticleId><ArticleId IdType="pubmed">33876908</ArticleId></ArticleIdList></Reference><Reference><Citation>Pająk A., Jankowski P., Zdrojewski T. The burden of cardiovascular disease risk factors: A current problem. Kardiol. Pol. 2022;80:5–15. doi: 10.33963/KP.a2022.0018.</Citation><ArticleIdList><ArticleId IdType="doi">10.33963/KP.a2022.0018</ArticleId><ArticleId IdType="pubmed">35137945</ArticleId></ArticleIdList></Reference><Reference><Citation>Núñez-Gil I.J., Feltes G., Viana-Llamas M.C., Raposeiras-Roubin S., Romero R., Alfonso-Rodríguez E., Uribarri A., Santoro F., Becerra-Muñoz V., Pepe M., et al. Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2) J. Clin. Med. 2023;12:706. doi: 10.3390/jcm12020706.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12020706</ArticleId><ArticleId IdType="pmc">PMC9863454</ArticleId><ArticleId IdType="pubmed">36675633</ArticleId></ArticleIdList></Reference><Reference><Citation>Oelsner E.C., Sun Y., Balte P.P., Allen N.B., Andrews H., Carson A., Cole S.A., Coresh J., Couper D., Cushman M., et al. Epidemiologic Features of Recovery From SARS-CoV-2 Infection. JAMA Netw. Open. 2024;7:e2417440. doi: 10.1001/jamanetworkopen.2024.17440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2024.17440</ArticleId><ArticleId IdType="pmc">PMC11184459</ArticleId><ArticleId IdType="pubmed">38884994</ArticleId></ArticleIdList></Reference><Reference><Citation>Vosko I., Zirlik A., Bugger H. Impact of COVID-19 on Cardiovascular Disease. Viruses. 2023;15:508. doi: 10.3390/v15020508.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020508</ArticleId><ArticleId IdType="pmc">PMC9962056</ArticleId><ArticleId IdType="pubmed">36851722</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezel-Potts E., Douiri A., Sun X., Chowienczyk P.J., Shah A.M., Gulliford M.C. Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK. PLoS Med. 2022;19:e1004052. doi: 10.1371/journal.pmed.1004052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004052</ArticleId><ArticleId IdType="pmc">PMC9295991</ArticleId><ArticleId IdType="pubmed">35853019</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583–590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan E.Y.F., Mathur S., Zhang R., Yan V.K.C., Lai F.T.T., Chui C.S.L., Li X., Wong C.K.H., Chan E.W.Y., Yiu K.H., et al. Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: A prospective cohort in UK Biobank. Cardiovasc. Res. 2023;119:1718–1727. doi: 10.1093/cvr/cvac195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvac195</ArticleId><ArticleId IdType="pubmed">36652991</ArticleId></ArticleIdList></Reference><Reference><Citation>la Roi-Teeuw H.M., van Smeden M., Geersing G.J., Klungel O.H., Rutten F.H., Souverein P.C., van Doorn S. Incidence and individual risk prediction of post-COVID-19 cardiovascular disease in the general population: A multivariable prediction model development and validation study. Eur. Heart J. Open. 2023;3:oead101. doi: 10.1093/ehjopen/oead101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjopen/oead101</ArticleId><ArticleId IdType="pmc">PMC10690016</ArticleId><ArticleId IdType="pubmed">38046622</ArticleId></ArticleIdList></Reference><Reference><Citation>Jud P., Gressenberger P., Muster V., Avian A., Meinitzer A., Strohmaier H., Sourij H., Raggam R.B., Stradner M.H., Demel U., et al. Evaluation of Endothelial Dysfunction and Inflammatory Vasculopathy After SARS-CoV-2 Infection-A Cross-Sectional Study. Front. Cardiovasc. Med. 2021;8:750887. doi: 10.3389/fcvm.2021.750887.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.750887</ArticleId><ArticleId IdType="pmc">PMC8549830</ArticleId><ArticleId IdType="pubmed">34722682</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID Collaborative Group Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: A prospective observational study. Lancet Respir. Med. 2022;10:761–775. doi: 10.1016/S2213-2600(22)00127-8. Erratum in: Lancet Respir. Med. 2022, 10, e85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Xiang M., Jing H., Wang C., Novakovic V.A., Shi J. Damage to endothelial barriers and its contribution to long COVID. Angiogenesis. 2024;27:5–22. doi: 10.1007/s10456-023-09878-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-023-09878-5</ArticleId><ArticleId IdType="pmc">PMC10134732</ArticleId><ArticleId IdType="pubmed">37103631</ArticleId></ArticleIdList></Reference><Reference><Citation>Szołtysek-Bołdys I., Zielińska-Danch W., Łoboda D., Gołba K.S., Sarecka-Hujar B. Assessment of the Concentrations of Selected Aminothiols in Patients after COVID-19. J. Clin. Med. 2024;13:4108. doi: 10.3390/jcm13144108.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13144108</ArticleId><ArticleId IdType="pmc">PMC11278428</ArticleId><ArticleId IdType="pubmed">39064148</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold N., Gori T., Schnabel R.B., Schulz A., Prochaska J.H., Zeller T., Binder H., Pfeiffer N., Beutel M., Espinola-Klein C., et al. Relation between Arterial Stiffness and Markers of Inflammation and Hemostasis—Data from the Population-based Gutenberg Health Study. Sci. Rep. 2017;7:6346. doi: 10.1038/s41598-017-06175-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-06175-2</ArticleId><ArticleId IdType="pmc">PMC5524791</ArticleId><ArticleId IdType="pubmed">28740206</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurent S., Boutouyrie P. Arterial Stiffness and Hypertension in the Elderly. Front. Cardiovasc. Med. 2020;7:544302. doi: 10.3389/fcvm.2020.544302.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.544302</ArticleId><ArticleId IdType="pmc">PMC7673379</ArticleId><ArticleId IdType="pubmed">33330638</ArticleId></ArticleIdList></Reference><Reference><Citation>Benetos A., Waeber B., Izzo J., Mitchell G., Resnick L., Asmar R., Safar M. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: Clinical applications. Am. J. Hypertens. 2002;15:1101–1108. doi: 10.1016/S0895-7061(02)03029-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-7061(02)03029-7</ArticleId><ArticleId IdType="pubmed">12460708</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Gullo A., Giuffrida C., Morace C., Squadrito G., Magnano San Lio P., Ricciardi L., Salvarani C., Mandraffino G. Arterial Stiffness and Adult Onset Vasculitis: A Systematic Review. Front. Med. 2022;9:824630. doi: 10.3389/fmed.2022.824630.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.824630</ArticleId><ArticleId IdType="pmc">PMC9133451</ArticleId><ArticleId IdType="pubmed">35646970</ArticleId></ArticleIdList></Reference><Reference><Citation>Poznyak A., Grechko A.V., Poggio P., Myasoedova V.A., Alfieri V., Orekhov A.N. The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. Int. J. Mol. Sci. 2020;21:1835. doi: 10.3390/ijms21051835.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21051835</ArticleId><ArticleId IdType="pmc">PMC7084712</ArticleId><ArticleId IdType="pubmed">32155866</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutouyrie P., Fliser D., Goldsmith D., Covic A., Wiecek A., Ortiz A., Martinez-Castelao A., Lindholm B., Massy Z.A., Suleymanlar G., et al. Assessment of arterial stiffness for clinical and epidemiological studies: Methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry. Nephrol. Dial Transplant. 2014;29:232–239. doi: 10.1093/ndt/gft309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gft309</ArticleId><ArticleId IdType="pubmed">24084326</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlachopoulos C., Xaplanteris P., Aboyans V., Brodmann M., Cífková R., Cosentino F., De Carlo M., Gallino A., Landmesser U., Laurent S., et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis. 2015;241:507–532. doi: 10.1016/j.atherosclerosis.2015.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2015.05.007</ArticleId><ArticleId IdType="pubmed">26117398</ArticleId></ArticleIdList></Reference><Reference><Citation>Millasseau S.C., Ritter J.M., Takazawa K., Chowienczyk P.J. Contour analysis of the photoplethysmographic pulse measured at the finger. J. Hypertens. 2006;24:1449–1456. doi: 10.1097/01.hjh.0000239277.05068.87.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.hjh.0000239277.05068.87</ArticleId><ArticleId IdType="pubmed">16877944</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunarathne A., Patel J.V., Hughes E.A., Lip G.Y. Measurement of stiffness index by digital volume pulse analysis technique: Clinical utility in cardiovascular disease risk stratification. Am. J. Hypertens. 2008;21:866–872. doi: 10.1038/ajh.2008.207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajh.2008.207</ArticleId><ArticleId IdType="pubmed">18551104</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimpour P., May J.M., Kyriacou P.A. Photoplethysmography for the Assessment of Arterial Stiffness. Sensors. 2023;23:9882. doi: 10.3390/s23249882.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/s23249882</ArticleId><ArticleId IdType="pmc">PMC10747425</ArticleId><ArticleId IdType="pubmed">38139728</ArticleId></ArticleIdList></Reference><Reference><Citation>Said M.A., Eppinga R.N., Lipsic E., Verweij N., van der Harst P. Relationship of Arterial Stiffness Index and Pulse Pressure With Cardiovascular Disease and Mortality. J. Am. Heart Assoc. 2018;7:e007621. doi: 10.1161/JAHA.117.007621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.117.007621</ArticleId><ArticleId IdType="pmc">PMC5850166</ArticleId><ArticleId IdType="pubmed">29358193</ArticleId></ArticleIdList></Reference><Reference><Citation>Homan T.D., Bordes S.J., Cichowski E.  StatPearls [Internet] StatPearls Publishing; Treasure Island, FL, USA: 2023.  [(accessed on 30 June 2024)]. Physiology, Pulse Pressure. Available online:  https://www.ncbi.nlm.nih.gov/books/NBK482408/</Citation><ArticleIdList><ArticleId IdType="pubmed">29494015</ArticleId></ArticleIdList></Reference><Reference><Citation>Visseren F.L.J., Mach F., Smulders Y.M., Carballo D., Koskinas K.C., Bäck M., Benetos A., Biffi A., Boavida J.M., Capodanno D., et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC) Rev. Esp. Cardiol. (Engl. Ed.) 2022;75:429. doi: 10.1016/j.rec.2022.04.003. In English and Spanish.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2022.04.003</ArticleId><ArticleId IdType="pubmed">35525570</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendrick M. Assessing cardiovascular disease: Looking beyond cholesterol. Curr. Opin. Endocrinol. Diabetes Obes. 2022;29:427–433. doi: 10.1097/MED.0000000000000761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MED.0000000000000761</ArticleId><ArticleId IdType="pubmed">35938775</ArticleId></ArticleIdList></Reference><Reference><Citation>Niiranen T.J., Kalesan B., Hamburg N.M., Benjamin E.J., Mitchell G.F., Vasan R.S. Relative Contributions of Arterial Stiffness and Hypertension to Cardiovascular Disease: The Framingham Heart Study. J. Am. Heart Assoc. 2016;5:e004271. doi: 10.1161/JAHA.116.004271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.116.004271</ArticleId><ArticleId IdType="pmc">PMC5210358</ArticleId><ArticleId IdType="pubmed">27912210</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., Yu S., Zhang H., Guo Z., Zheng Y., Xu Z., Li Z., Liu X., Li X., Chen S., et al. Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes. Cardiovasc. Diabetol. 2022;21:262. doi: 10.1186/s12933-022-01696-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01696-1</ArticleId><ArticleId IdType="pmc">PMC9706858</ArticleId><ArticleId IdType="pubmed">36443820</ArticleId></ArticleIdList></Reference><Reference><Citation>Szoltysek-Boldys I., Zielinska-Danch W., Loboda D., Wilczek J., Gibinski M., Paradowska-Nowakowska E., Golba K.S., Sarecka-Hujar B. Photoplethysmographic Measurement of Arterial Stiffness in Polish Patients with Long-COVID-19 Syndrome-The Results of a Cross-Sectional Study. Diagnostics. 2022;12:3189. doi: 10.3390/diagnostics12123189.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12123189</ArticleId><ArticleId IdType="pmc">PMC9777579</ArticleId><ArticleId IdType="pubmed">36553195</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 30 June 2024)].  Available online:  https://data.who.int/dashboards/covid19/cases.</Citation></Reference><Reference><Citation>SCORE2 Working Group and ESC Cardiovascular Risk Collaboration SCORE2 risk prediction algorithms: New models to estimate 10-year risk of cardiovascular disease in Europe. Eur. Heart J. 2021;42:2439–2454. doi: 10.1093/eurheartj/ehab309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab309</ArticleId><ArticleId IdType="pmc">PMC8248998</ArticleId><ArticleId IdType="pubmed">34120177</ArticleId></ArticleIdList></Reference><Reference><Citation>Łoboda D., Gibiński M., Wilczek J., Paradowska-Nowakowska E., Ekiert K., Rybicka E., Sarecka-Hujar B., Szołtysek-Bołdys I., Zielińska-Danch W., Gołba K.S. Effectiveness of cardiopulmonary rehabilitation after COVID-19 in Poland. Pol. Arch. Intern. Med. 2023;133:16341. doi: 10.20452/pamw.16341.</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.16341</ArticleId><ArticleId IdType="pubmed">36093967</ArticleId></ArticleIdList></Reference><Reference><Citation>Asmar R., Vol S., Brisac A.M., Tichet J., Topouchian J. Reference values for clinic pulse pressure in a nonselected population. Pt 1Am. J. Hypertens. 2001;14:415–418. doi: 10.1016/S0895-7061(01)01284-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-7061(01)01284-5</ArticleId><ArticleId IdType="pubmed">11368460</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynn R.J., Chae C.U., Guralnik J.M., Taylor J.O., Hennekens C.H. Pulse pressure and mortality in older people. Arch. Intern. Med. 2000;160:2765–2772. doi: 10.1001/archinte.160.18.2765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.160.18.2765</ArticleId><ArticleId IdType="pubmed">11025786</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancusi C., Losi M.A., Izzo R., Canciello G., Carlino M.V., Albano G., De Luca N., Trimarco B., de Simone G. Higher pulse pressure and risk for cardiovascular events in patients with essential hypertension: The Campania Salute Network. Eur. J. Prev. Cardiol. 2018;25:235–243. doi: 10.1177/2047487317747498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2047487317747498</ArticleId><ArticleId IdType="pubmed">29226693</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.B., Baek H.J. Photoplethysmography in Wearable Devices: A Comprehensive Review of Technological Advances, Current Challenges, and Future Directions. Electronics. 2023;12:2923. doi: 10.3390/electronics12132923.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/electronics12132923</ArticleId></ArticleIdList></Reference><Reference><Citation>Brillante D.G., O’Sullivan A.J., Howes L.G. Arterial stiffness indices in healthy volunteers using non-invasive digital photoplethysmography. Blood Press. 2008;17:116–123. doi: 10.1080/08037050802059225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08037050802059225</ArticleId><ArticleId IdType="pubmed">18568701</ArticleId></ArticleIdList></Reference><Reference><Citation>CareFusion PulseTrace PCA2 Operating Manual.  [(accessed on 30 June 2024)].  Available online:  https://www.bioclinicalservices.com.au/micro-medical-limited/clinical/carefusion-pulsetrace-pca2-operating-manual-issue-1-feb-2010.</Citation></Reference><Reference><Citation>Vallée A. Arterial stiffness and biological parameters: A decision tree machine learning application in hypertensive participants. PLoS ONE. 2023;18:e0288298. doi: 10.1371/journal.pone.0288298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0288298</ArticleId><ArticleId IdType="pmc">PMC10328363</ArticleId><ArticleId IdType="pubmed">37418473</ArticleId></ArticleIdList></Reference><Reference><Citation>Flisiak R., Horban A., Jaroszewicz J., Kozielewicz D., Mastalerz-Migas A., Owczuk R., Parczewski M., Pawłowska M., Piekarska A., Simon K., et al. Management of SARS-CoV-2 infection: Recommendations of the Polish Association of Epidemiologists and Infectiologists as of April 26, 2021. Pol. Arch. Intern. Med. 2021;131:487–496. doi: 10.20452/pamw.15979.</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.15979</ArticleId><ArticleId IdType="pubmed">33908727</ArticleId></ArticleIdList></Reference><Reference><Citation>Freiberg A., Schubert M., Romero Starke K., Hegewald J., Seidler A.A. Rapid Review on the Influence of COVID-19 Lockdown and Quarantine Measures on Modifiable Cardiovascular Risk Factors in the General Population. Int. J. Environ. Res. Public Health. 2021;18:8567. doi: 10.3390/ijerph18168567.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18168567</ArticleId><ArticleId IdType="pmc">PMC8393482</ArticleId><ArticleId IdType="pubmed">34444316</ArticleId></ArticleIdList></Reference><Reference><Citation>Warhadpande M., Sainz K., Jacobson M.S. Effects of the COVID-19 Pandemic on Pediatric and Adolescent ASCVD Risk Factors. Curr. Atheroscler. Rep. 2023;25:591–596. doi: 10.1007/s11883-023-01130-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11883-023-01130-1</ArticleId><ArticleId IdType="pubmed">37470956</ArticleId></ArticleIdList></Reference><Reference><Citation>Conroy R.M., Pyörälä K., Fitzgerald A.P., Sans S., Menotti A., De Backer G., De Bacquer D., Ducimetière P., Jousilahti P., Keil U., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur. Heart J. 2003;24:987–1003. doi: 10.1016/S0195-668X(03)00114-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0195-668X(03)00114-3</ArticleId><ArticleId IdType="pubmed">12788299</ArticleId></ArticleIdList></Reference><Reference><Citation>Tąpolska M., Spałek M., Szybowicz U., Domin R., Owsik K., Sochacka K., Skrypnik D., Bogdański P., Owecki M. Arterial Stiffness Parameters Correlate with Estimated Cardiovascular Risk in Humans: A Clinical Study. Int. J. Environ. Res. Public Health. 2019;16:2547. doi: 10.3390/ijerph16142547.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph16142547</ArticleId><ArticleId IdType="pmc">PMC6678098</ArticleId><ArticleId IdType="pubmed">31319466</ArticleId></ArticleIdList></Reference><Reference><Citation>Goff D.C., Jr., Lloyd-Jones D.M., Bennett G., Coady S., D’Agostino R.B., Sr., Gibbons R., Greenland P., Lackland D.T., Levy D., O’Donnell C.J., et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2014;63 Pt B:2935–2959. doi: 10.1016/j.jacc.2013.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.11.005</ArticleId><ArticleId IdType="pmc">PMC4700825</ArticleId><ArticleId IdType="pubmed">24239921</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Agostino R.B., Sr., Vasan R.S., Pencina M.J., Wolf P.A., Cobain M., Massaro J.M., Kannel W.B. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation. 2008;117:743–753. doi: 10.1161/CIRCULATIONAHA.107.699579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.699579</ArticleId><ArticleId IdType="pubmed">18212285</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafyllias K., Liverakos S., Muthuraman M., Cavagna L., Parodis I., Schwarting A. Cardiovascular Risk Evaluation in Psoriatic Arthritis by Aortic Stiffness and the Systemic Coronary Risk Evaluation (SCORE): Results of the Prospective PSOCARD Cohort Study. Rheumatol. Ther. 2024;11:897–911. doi: 10.1007/s40744-024-00676-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40744-024-00676-z</ArticleId><ArticleId IdType="pmc">PMC11265042</ArticleId><ArticleId IdType="pubmed">38819779</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyle D., Boylan L., Wilson L., Haining S., Oates C., Sims A., Guri I., Allen J., Wilkes S., Stansby G. Accuracy of Peripheral Arterial Disease Registers in UK General Practice: Case-Control Study. J. Prim. Care Community Health. 2020;11:2150132720946148. doi: 10.1177/2150132720946148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2150132720946148</ArticleId><ArticleId IdType="pmc">PMC7513392</ArticleId><ArticleId IdType="pubmed">32959726</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowienczyk P.J., Kelly R.P., MacCallum H., Millasseau S.C., Andersson T.L., Gosling R.G., Ritter J.M., Anggård E.E. Photoplethysmographic assessment of pulse wave reflection: Blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J. Am. Coll. Cardiol. 1999;34:2007–2014. doi: 10.1016/S0735-1097(99)00441-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(99)00441-6</ArticleId><ArticleId IdType="pubmed">10588217</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>